These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
524 related items for PubMed ID: 21245592
1. 18F-FDG PET/CT imaging in oncology. Almuhaideb A, Papathanasiou N, Bomanji J. Ann Saudi Med; 2011; 31(1):3-13. PubMed ID: 21245592 [Abstract] [Full Text] [Related]
3. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review. Chowdhury FU, Shah N, Scarsbrook AF, Bradley KM. Postgrad Med J; 2010 Mar; 86(1013):174-82. PubMed ID: 20237012 [Abstract] [Full Text] [Related]
4. Integrated FDG PET/CT: Utility and Applications in Clinical Oncology. Pinilla I, Rodríguez-Vigil B, Gómez-León N. Clin Med Oncol; 2008 Mar; 2():181-98. PubMed ID: 21892279 [Abstract] [Full Text] [Related]
5. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective. Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Elcim Y, Gundem E, Dirican B, Beyzadeoglu M. Curr Radiopharm; 2019 Mar; 12(1):4-10. PubMed ID: 30465520 [Abstract] [Full Text] [Related]
6. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M. Acta Gastroenterol Belg; 2007 Mar; 70(4):331-8. PubMed ID: 18330088 [Abstract] [Full Text] [Related]
11. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma. Kitajima K, Suenaga Y, Sugimura K. Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982 [Abstract] [Full Text] [Related]
12. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Facey K, Bradbury I, Laking G, Payne E. Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839 [Abstract] [Full Text] [Related]
13. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT. Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [Abstract] [Full Text] [Related]
15. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J, Shimosegawa E, Kanakura Y, Nakamura H, Hatazawa J. Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558 [Abstract] [Full Text] [Related]
16. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients. Endo K, Oriuchi N, Higuchi T, Iida Y, Hanaoka H, Miyakubo M, Ishikita T, Koyama K. Int J Clin Oncol; 2006 Aug; 11(4):286-96. PubMed ID: 16937302 [Abstract] [Full Text] [Related]
19. PET/CT for the staging and follow-up of patients with malignancies. Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595 [Abstract] [Full Text] [Related]